| CAS NO: | 92933-48-7 |
| 包装 | 价格(元) |
| 100mg | 电议 |
| 250mg | 电议 |
| 500mg | 电议 |
| 生物活性 |
LUF6283 is a potent and orally activeHCA(2)partial agonist, with aKiof 0.55 μM. LUF6283 can achieve the beneficial lipid lowering effect of niacin without producing the unwanted cutaneous flushing side effect[1]. |
| IC50& Target |
EC50: 0.32 ± 0.06 μM (pERK1/2)[1] |
| 体内研究 (In Vivo) |
LUF6283 (C57BL/6 mice, 400 mg/kg, Oral gavage, once a day for 4 weeks) has no effect on adipose tissue ATGL/HSL expression, and significantly reduces the expression of apolipoprotein B (APOB)[1].
|
| 分子量 |
168.19 |
| Formula |
C8H12N2O2 |
| CAS 号 |
92933-48-7 |
| 运输条件 |
Room temperature in continental US; may vary elsewhere. |
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com
